Skip to main content
. 2021 Jun 30;11(6):e050582. doi: 10.1136/bmjopen-2021-050582

Table 2.

Schedule for study enrolment, intervention and assessments

Activity/assessment Recruitment Enrolment Follow-up30days Follow-up90days Follow-up180days
Time point T−1 T0 T1 T2 T3
Prescreening (positive PCR test) x
Information to e-Boks x
Informed e-consent x
Eligibility screening x
Baseline questionnaire x
Randomisation/group allocation x
Video guides x
PEP flute deliverance x (+3 days)
Self-report of symptoms (CAT) x (day 1-30)
Intervention group: PEP usage x (day 1-30)
Compliance assessment x (day 30)
Outcome assessment x x x
Baseline/outcome variables*
Age and sex (register data) x
Symptoms within last week x x x x
Cohabitation x
Education x
Health literacy (two dimensions) x
Profession and employment x
Self-rated health (one item) x x x x
Weight and height x
Smoking and alcohol x
Comorbidity self-reported x
Comorbidity (register data) x
CAT score x x x x
Hospital admission (register data) x x
Medication (register data) x x
Death (register data) x x
Serious adverse event As needed throughout protocol

*All baseline and outcome variables are collected as questionnaire data unless stated otherwise.

CAT, COPD Assessment Test; PEP, positive expiratory pressure.